KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Clorox (CLX) EBIT (2016 - 2025)

Clorox (CLX) has 17 years of EBIT data on record, last reported at $431.0 million in Q4 2025.

  • For Q4 2025, EBIT rose 0.94% year-over-year to $431.0 million; the TTM value through Dec 2025 reached $1.8 billion, down 8.77%, while the annual FY2025 figure was $2.0 billion, 12.14% up from the prior year.
  • EBIT reached $431.0 million in Q4 2025 per CLX's latest filing, up from $291.0 million in the prior quarter.
  • Across five years, EBIT topped out at $596.0 million in Q2 2025 and bottomed at $227.0 million in Q3 2023.
  • Average EBIT over 5 years is $418.0 million, with a median of $429.0 million recorded in 2024.
  • Peak YoY movement for EBIT: plummeted 46.4% in 2021, then soared 118.06% in 2024.
  • A 5-year view of EBIT shows it stood at $283.0 million in 2021, then rose by 7.77% to $305.0 million in 2022, then soared by 67.87% to $512.0 million in 2023, then decreased by 16.6% to $427.0 million in 2024, then rose by 0.94% to $431.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $431.0 million in Q4 2025, $291.0 million in Q3 2025, and $596.0 million in Q2 2025.